Related Experiment Video
Updated: Apr 15, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia
Morgan E Wallace1, Marice B Alcantara1, Yosuke Minoda1
1Federation University, Ballarat, Victoria, Australia; Fiona Elsey Cancer Research Institute, Ballarat, Victoria, Australia.
Abstract:
The last few years has seen the burgeoning of a new category of therapeutics for cancer targeting immune regulatory pathways. Antibodies that block the PD-1/PD-L1 interaction are perhaps the most prominent of these new anti-cancer therapies, but several other inhibitory receptor ligand interactions have also shown promise as targets in clinical trials, including CTLA-4/CD80 and Lag-3/MHC class II. Related to this is a rapidly improving knowledge of 'regulatory' lymphocyte lineages, including NKT cells, MAIT cells, B regulatory cells and others. These cells have potent cytokine responses that can influence the functioning of other immune cells and many researchers believe that they could be effective targets for therapies designed to enhance immune responses to cancer. This review will outline our current understanding of FOXP3+ 'Tregs', NKT cells, MAIT cells and B regulatory cells immune regulatory cell populations in cancer, with a particular focus on chronic lymphocytic leukaemia (CLL). We will discuss evidence linking CLL with immune regulatory dysfunction and the potential for new therapies targeting regulatory cells.
Insights
New cancer therapies target immune pathways. This review covers regulatory cells like FOXP3+ Tregs, NKT, MAIT, and B regulatory cells, focusing on their role in chronic lymphocytic leukemia (CLL) and potential therapeutic strategies.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- The development of novel cancer therapeutics targeting immune regulatory pathways has surged.
- Immune checkpoint inhibitors, such as antibodies blocking PD-1/PD-L1, are prominent examples.
- Other targets include CTLA-4/CD80 and Lag-3/MHC class II interactions, with ongoing clinical trials.
Purpose of the Study:
- To review the current understanding of immune regulatory cell populations in cancer.
- To specifically focus on FOXP3+ regulatory T cells (Tregs), NKT cells, MAIT cells, and B regulatory cells.
- To explore the link between chronic lymphocytic leukemia (CLL) and immune regulatory dysfunction.
Main Methods:
- Literature review of recent advancements in cancer immunology.
- Analysis of research on regulatory lymphocyte lineages and their functions.
- Examination of studies investigating immune dysfunction in CLL.
Main Results:
- Regulatory lymphocyte lineages, including NKT, MAIT, and B regulatory cells, possess potent cytokine responses influencing anti-cancer immunity.
- FOXP3+ Tregs play a significant role in immune regulation within the tumor microenvironment.
- Evidence suggests a connection between CLL and impaired immune regulation.
Conclusions:
- Targeting regulatory cells offers a promising avenue for enhancing anti-cancer immune responses.
- Understanding the dysfunction of regulatory cells in CLL may lead to novel therapeutic strategies.
- Further research into these cell populations could revolutionize cancer treatment.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Functions of the Lymphatic and Immune System
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cells of the Adaptive Immune Response
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

